Dynamic Change of Clinical Characteristics in a Cured Patient with Influenza A (H7N9) Virus Infection

Cheng Chen,Qiang Guo,Yukun Zhang,Xiaomin Wu,Jianping Yang,Jun Chen,Jianan Huang

DOI: https://doi.org/10.3760/cma.j.issn.0366-6999.20132233

2014-01-01

Abstract:To the editor: During the spring of 2013, a novel avian-origin influenza A (H7N9) virus emerged and spread among humans in China.1 In this report, we described the dynamic change of clinical characteristics in a case of H7N9 virus infection, who got cured without treatment with invasive mechanical ventilation. A 54-year-old patient was admitted to our hospital on April 12, 2013 with complaint of fever and cough for 1 week. Based on the chest CT scan (April 11, day -1), a diagnosis of pneumonia was made and the patient was put on antibiotics (ceftazidime) and oxygen therapy. Antiviral treatment (oseltamivir) and intravenous methylprednisolone (80 mg/d) were also initiated on admission. Two days after admission, the laboratory confirmation of avianorigin influenza A (H7N9) infection was made, along with a rapid deterioration of PaO2/FiO2 (PaO2:FiO2=160, Figure 1A). X-ray also showed rapid progression of an increase in bilateral groundglass opacities and areas of consolidation. Administration of intravenous methylprednisolone was increased from the second day (240 mg/d). Although persistent respiratory insufficiency occurred, invasive mechanical ventilation was not applied to the patient, instead of non-invasive mechanical ventilation (the seventh day). Fluoroquinolones and cefoperazone-sulbactam were administrated to the patient because of occurrence of purulent sputum (the seventh day). No pathogens were isolated from blood. Only mold was isolated from sputum 2 weeks after admission. Anti-fungal agents were not administered to the patient. Administration of methylprednisolone was reduced on the fifth day (120 mg/d) and again on the eighth day (40 mg/d). It was withdrawn on the 10th day after admission.Figure 1.: The dynamic change of PaO2/FiO2 (A) and level of lactate dehydrogenase (B, LDH), creatine kinase (B, CK), white cells (C, WBC), and lymphocytes (C, L) over a 9-week period. Oxygen therapy is shown in A.By comprehensive management strategies, the level of WBC recovered completely 2 weeks after admission; lymphocyte, PaO2:FiO2, lactate dehydrogenase (LDH) and creatine kinase (CK) recovered completely 3 weeks after admission (Figure 1). Although improvements were observed in the X-ray and chest CT within 1 week of admission, a mild progress in chest CT was repeated on the 10th and 13th admissive days. An obvious decrease in bilateral ground-glass opacities and areas of consolidation was noticed within 3 weeks of admission. Also after 3 weeks, the patient had no detectable viruses in the airway; the antiviral and oxygen treatment were stopped the next week. Slow absorption of lung lesions and secondary pulmonary fibrosis were observed in the chest CT in the follow-up visits (Figure 2).Figure 2.: Computed tomographic scans of the chest. On day 7 after admission, ground-glass opacities and partial consolidation were decreased in the upper and lower portions of the right lung, along with increase of ground-glass opacities in the left lung, compared to 1 day before admission. On day 10, there was mild progression. On day 22, there were decreased ground-glass opacities and consolidation in both lungs. On day 29, groundglass opacities and consolidation in both lungs continued to resolve.As reported previously, the patient has typical clinical characteristics of virus pneumonia.2,3 Although rapid progression in CT occurred, the levels of LDH and CK began to decrease 2 days after admission. The complete recovery time of the levels of lymphocyte, LDH, and CK was in accordance with the resolving time of chest CT and virus negative-conversion time. Antiviral treatment was initiated on the 8th day after onset of illness and treated continuously for 4 weeks. These findings suggested that improvement of enzymology and lymphopenia is linked to good outcome of disease, which might depend on clearing the virus. Although persistent respiratory insufficiency occurred, oxygen therapy and short-term NIPPV maintained oxygenation index of more than 120 and no lactic acidosis, and ultimately invasive ventilation was avoided. Although the application of glucocorticoid in viral pneumonia and ARDS is controversial, it is suggested that early and short-term application of glucocorticoid in H7N9 patient can reduce the inflammation response and maintain oxygenation.